Dr. Gao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
251 E Huron St
# Feinberg
Chicago, IL 60611Phone+1 312-926-3211Fax+1 312-695-6680
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Hematopathology, 2010 - 2012- McGaw Medical Center of Northwestern UniversityResidency, Pathology-Anatomic and Clinical, 2006 - 2010
Shanghai Medical UniversityClass of 1998
Certifications & Licensure
IL State Medical License 2009 - 2026- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Pathology - Molecular Genetic
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Transdifferentiation of metastatic melanoma into cerebellar angiosarcoma.Nicolas Kostelecky, Nitin Wadhwani, Ivana Golubovich, Erica Vormittag-Nocito, Juehua Gao
Journal of Neuropathology and Experimental Neurology. 2024-12-01 - Detection and Interpretation of Clonal Hematopoiesis Variants during Routine Solid Tumor Next-Generation Sequencing: A Single-Institution Experience.Adil Menon, Madina Sukhanova, Kevin L Nocito, Juehua Gao, Lawrence J Jennings
The Journal of Molecular Diagnostics. 2024-12-01 - Therapy-related myeloid neoplasms following curative treatment of acute promyelocytic leukemia: incidence, correlation with therapeutic regimen, and future directions.Adil Menon, Madina Sukhanova, Juehua Gao, Kristy Wolniak, Lucy Fu
Journal of Hematopathology. 2024-12-01
Abstracts/Posters
- Ibrutinib Maintenance (I-M) Following Frontline Intensive Induction in Mantle Cell Lymphoma (MCL): Interim Safety, Response and Sequential MRD EvaluationJuehua Gao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Ibrutinib Maintenance (I-M) Following Frontline Intensive Induction in Mantle Cell Lymphoma (MCL): Interim Safety, Response and Sequential MRD EvaluationJuehua Gao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
